Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




New Generation of Antibiotics Disrupts Quorum Sensing

By LabMedica International staff writers
Posted on 24 Mar 2009
Drug developers are working on a new generation of antibiotics that do not kill bacteria but instead disrupt the communication system known as "quorum sensing,” which induces the microorganisms to manufacture disease-causing toxins.

Several types of bacteria, including such human pathogens as Vibrio cholerae and Escherichia coli O157:H7, can grow within a host without harming it, until they reach a certain concentration. They become aggressive when their numbers become sufficient to overcome the host's immune system and form a biofilm, leading to disease. The language of quorum sensing is based on the bacterial population producing and detecting signaling molecules known as autoinducers.

Investigators from the Albert Einstein College of Medicine (New York, NY, USA) focused on the bacterial enzyme 5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase (MTAN), which is involved in S-adenosylmethionine–related quorum sensing pathways that induce bacterial pathogenesis factors. To block MTAN activity they created a series of transition state analogs, MT-DADMe-Immucillin-A, EtT-DADMe-Immucillin-A, and BuT-DADMe-Immucillin-A, which are slow-onset, tight-binding inhibitors of V. cholerae MTAN (VcMTAN).

Results published in the March 8, 2009, online edition of the journal Nature Chemical Biology revealed that in V. cholerae cells, the compounds were potent MTAN inhibitors. Structural analysis of VcMTAN with BuT-DADMe-Immucillin-A revealed interactions contributing to the high affinity. The compounds disrupted autoinducer production in a dose-dependent manner without affecting growth. MT- and BuT-DADMe-Immucillin-A also inhibited autoinducer-2 production in enterohemorrhagic E. coli O157:H7.

By targeting quorum sensing rather than bacterial growth, the new drugs avoided stimulating the bacteria into becoming resistant. The investigators tested the compounds on 26 successive generations of both bacterial species, and found that the 26th generations were as sensitive to the antibiotics as the first. "In our lab, we call these agents everlasting antibiotics,” said senior author Dr. Vern Schramm, professor of biochemistry at Albert Einstein College of Medicine.

Related Links:

Albert Einstein College of Medicine



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.